<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   719
  </number>
  <updateDate>
   2023-05-11T15:45:15Z
  </updateDate>
  <updateDateIncludingText>
   2023-05-11T15:45:15Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-02-02
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 19 (Tuesday, February 2, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. McHENRY:H.R. 719.Congress has the power to enact this legislation pursuantto the following:Amendment X: The powers not delegated to the United Statesby the Constitution, nor prohibited by it to the states, arereserved to the states respectively, or to the people;Article I, Section 8, Clause 3: To regulate Commerce withforeign Nations, and among the several states, and with theIndian Tribes;Article I, Section 8, Clause 18: To make all Laws whichshall be necessary and proper for carrying into Execution theforegoing powers, and all other Powers vested by thisConstitution in the Government of the United States, or inany Department or Officer thereof.[Page H280]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-03T19:23:22Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-02-02T19:05:45Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Right to Test Act
    </title>
    <congress>
     117
    </congress>
    <number>
     152
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-02-02
     </actionDate>
     <text>
      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-02-03
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-02
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     M001156
    </bioguideId>
    <fullName>
     Rep. McHenry, Patrick T. [R-NC-10]
    </fullName>
    <firstName>
     Patrick
    </firstName>
    <lastName>
     McHenry
    </lastName>
    <party>
     R
    </party>
    <state>
     NC
    </state>
    <district>
     10
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     R000614
    </bioguideId>
    <fullName>
     Rep. Roy, Chip [R-TX-21]
    </fullName>
    <firstName>
     Chip
    </firstName>
    <lastName>
     Roy
    </lastName>
    <party>
     R
    </party>
    <state>
     TX
    </state>
    <district>
     21
    </district>
    <sponsorshipDate>
     2021-02-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001108
    </bioguideId>
    <fullName>
     Rep. Comer, James [R-KY-1]
    </fullName>
    <firstName>
     James
    </firstName>
    <lastName>
     Comer
    </lastName>
    <party>
     R
    </party>
    <state>
     KY
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-02-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Medical tests and diagnostic methods
     </name>
    </item>
    <item>
     <name>
      State and local government operations
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-02-02
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-03-17T15:03:08Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Right to Test Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. &lt;/p&gt; &lt;p&gt;Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device.&lt;/p&gt; &lt;p&gt;Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Right to Test Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Right to Test Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To allow States to approve the use of diagnostic tests during a public health emergency.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Right to Test Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-02-02T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr719ih/xml/BILLS-117hr719ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-03
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-03
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-02
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
2021-02-02T19:05:45Z
Referred to
House
Energy and Commerce Committee
2021-02-03T19:23:22Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
R000614
21
Chip
Rep. Roy, Chip [R-TX-21]
Roy
R
2021-02-02
TX
C001108
1
James
Rep. Comer, James [R-KY-1]
Comer
R
2021-02-02
KY
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-02-02
2021-02-03
Referred to the Subcommittee on Health.
House
Health
2021-02-02
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Identical bill
Right to Test Act
S
M001156
10
Patrick
Rep. McHenry, Patrick T. [R-NC-10]
N
McHenry
R
NC
Cardiovascular and respiratory health Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Health technology, devices, supplies Infectious and parasitic diseases Medical tests and diagnostic methods State and local government operations
2021-02-02
Introduced in House
 <p><b>Right to Test Act</b></p> <p>This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. </p> <p>Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device.</p> <p>Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.</p>
2021-03-17T15:03:08Z
00
2021-02-02T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr719ih/xml/BILLS-117hr719ih.xml
Right to Test Act
Right to Test Act
Display Title
IH
Introduced in House
To allow States to approve the use of diagnostic tests during a public health emergency.
Official Title as Introduced
IH
Introduced in House
Right to Test Act
Short Title(s) as Introduced
HR
2023-05-11T15:45:15Z
2023-05-11T15:45:15Z
3.0.0
2021-02-02
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Identical bill
Right to Test Act
S
2021-02-03
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-02
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-02
9
Library of Congress
Introduced in House
IntroReferral
M001156
10
Patrick
Rep. McHenry, Patrick T. [R-NC-10]
N
McHenry
R
NC
R000614
21
Chip
Rep. Roy, Chip [R-TX-21]
Roy
R
2021-02-02
TX
C001108
1
James
Rep. Comer, James [R-KY-1]
Comer
R
2021-02-02
KY
Cardiovascular and respiratory health Drug safety, medical device, and laboratory regulation Emergency medical services and trauma care Health technology, devices, supplies Infectious and parasitic diseases Medical tests and diagnostic methods State and local government operations
2021-02-02
Introduced in House
 <p><b>Right to Test Act</b></p> <p>This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency. </p> <p>Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device.</p> <p>Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.</p>
2021-03-17T15:03:08Z
00
Right to Test Act
Right to Test Act
Display Title
IH
Introduced in House
To allow States to approve the use of diagnostic tests during a public health emergency.
Official Title as Introduced
IH
Introduced in House
Right to Test Act
Short Title(s) as Introduced
2021-02-03
Referred to the Subcommittee on Health.